AXA World Funds - Switzerland Equity F Capitalisation CHFRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.9 | 19.0 | -11.1 | 8.8 | 1.2 | |
+/-Cat | 4.5 | -0.9 | -2.3 | -2.2 | 1.2 | |
+/-B’mrk | - | -3.3 | -3.8 | 0.1 | 1.4 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 19/04/2024 | CHF 103.24 | |
Day Change | 0.44% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU0087657408 | |
Fund Size (Mil) 19/04/2024 | CHF 304.65 | |
Share Class Size (Mil) 19/04/2024 | CHF 90.37 | |
Max Initial Charge | 2.00% | |
Ongoing Charge 31/12/2023 | 1.02% |
Investment Objective: AXA World Funds - Switzerland Equity F Capitalisation CHF |
To seek long-term growth of your investment, in CHF, from an actively managed listed equity, equity-related securities and derivatives portfolio. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Hervé Mangin 18/12/2017 | ||
Benoit Labeyrie 27/01/2023 | ||
Inception Date 20/06/1990 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
60% SPI Middle Caps TR CHF , 40% SPI Large Caps TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA World Funds - Switzerland Equity F Capitalisation CHF | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Nestle SA | Consumer Defensive | 8.49 |
Roche Holding AG | Healthcare | 5.90 |
Julius Baer Gruppe AG | Financial Services | 4.42 |
Lonza Group Ltd | Healthcare | 4.41 |
Novartis AG Registered Shares | Healthcare | 4.16 |
Increase Decrease New since last portfolio | ||
AXA World Funds - Switzerland Equity F Capitalisation CHF |